Bioresorbable Collagen Implant Market Size & Share, by Type (Dermal Fillers, Orthopedic Implants), End User (Hospitals, Surgical Centers, Dermatology Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5317
  • Published Date: Oct 13, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Bioresorbable Collagen Implant Market size is poised to cross USD 20 billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of bioresorbable collagen implants was over USD 10 billion. Bioresorbable collagen implants are often used in aesthetic procedures such as facial fillers and lip augmentation. The growing demand for non-surgical cosmetic treatments could drive market growth. Collagen implants can be used in orthopedic surgeries, such as tendon and ligament repair. As the aging population increases and the incidence of sports-related injuries rises, the demand for these implants may also grow.

Bioresorbable collagen implants are medical devices used in various fields of medicine, including plastic surgery, orthopedics, and wound care. These implants are made from collagen, a protein found in connective tissues, and they are designed to gradually degrade and be absorbed by the body over time. This feature makes them useful for tissue repair and regeneration. Increasing awareness among both patients and healthcare providers about the benefits of bioresorbable collagen implants can contribute to market expansion. The bioresorbable collagen implant market refers to a specialized segment within the medical and healthcare industry that focuses on the development, manufacturing, and distribution of medical devices made from collagen-based materials. These implants are designed to be inserted into the human body to serve various therapeutic and cosmetic purposes, and they possess the unique characteristic of being biodegradable or bioresorbable.


Get more information on this report: Request Free Sample PDF

Bioresorbable Collagen Implant Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Demand for Non-Surgical Aesthetic Procedures: Increasing consumer preference for minimally invasive and non-surgical cosmetic enhancements, such as facial fillers and lip augmentation, is driving the demand for collagen-based implants. Patients seek treatments that offer natural-looking results with reduced downtime, contributing to bioresorbable collagen implant market growth. According to a report, global dermal filler sales, which include collagen-based products, are projected to reach USD 13 billion by 2027.
  • Technological Advancements in Collagen Implants: Continuous innovation in collagen implant materials and manufacturing processes has led to the development of more effective and longer-lasting products. These advancements enhance overall performance and patient satisfaction, further propelling market expansion. Ongoing advancements in collagen-based implant materials are driving the market growth.
  • Orthopedic Applications and Aging Population: Collagen implants are utilized in orthopedic surgeries, particularly for tendon and ligament repair. As the global population ages, the prevalence of orthopedic conditions and sports-related injuries is increasing. This demographic shift is a significant growth driver for collagen implants in orthopedics.
  • Rising Demand for Tissue Engineering and Regenerative Medicine: Tissue engineering and regenerative medicine are rapidly evolving fields that focus on restoring or regenerating damaged or lost tissues and organs in the body. Bioresorbable collagen implants play a pivotal role in these applications. Bioresorbable collagen implants act as scaffolds in tissue engineering. When implanted in the body, they provide a structure for new cells to adhere to and grow, facilitating the regeneration of damaged tissues. For instance, in orthopedics, collagen implants can be used to repair damaged tendons or ligaments.
  • Growing Popularity of Cosmetic and Aesthetic Procedures: The cosmetic and aesthetic industry is experiencing significant growth globally, and bioresorbable collagen implants are increasingly adopted for non-surgical aesthetic enhancements. Collagen-based dermal fillers are commonly used for facial rejuvenation. They can fill in wrinkles, fine lines, and volume loss, providing a youthful appearance. Patients prefer these minimally invasive treatments due to their convenience and shorter recovery periods. Lip augmentation is a popular aesthetic procedure that often utilizes collagen implants.

Challenges

  1. Regulatory Compliance and Approval: The stringent regulatory requirements for medical devices, including collagen implants, can pose challenges for manufacturers. Meeting these standards, obtaining approvals, and navigating regulatory changes can be time-consuming and costly. The development, manufacturing, and distribution of bioresorbable collagen implants are subject to rigorous regulatory oversight in most countries. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe set stringent standards to ensure the safety, efficacy, and quality of medical devices, including collagen implants.
  2. Product Development Costs are High
  3. Competition in the Market

Bioresorbable Collagen Implant Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~8%

Base Year Market Size (2023)

~ USD 10 Billion

Forecast Year Market Size (2036)

~ USD 20 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Bioresorbable Collagen Implant Segmentation

Type (Dermal Fillers, Orthopedic Implants)

The orthopedic implants segment is estimated to hold 61% share of the global bioresorbable collagen implant market by 2036. Bioresorbable collagen implants offer a minimally invasive approach for orthopedic procedures. Patients are more inclined toward procedures with quicker recovery, making collagen implants an attractive option. Minimally invasive surgeries are associated with shorter hospital stays and reduced recovery times, benefiting patients. Aging populations, advancements in implant technology, and a preference for minimally invasive procedures are driving demand for these products. Additionally, the alignment of collagen implants with regenerative medicine principles and their biocompatibility contribute to their increasing adoption in orthopedic applications.

End Users (Hospitals, Surgical Centers, Dermatology Clinics)

Bioresorbable collagen implant market from the hospitals segment is expected to garner a significant share in the year 2036. Hospitals are early adopters of innovative medical technologies, including bioresorbable collagen implants. Technological advancements in these implants improve patient outcomes, making hospitals more inclined to integrate them into their procedures. The global medical device sales are projected to reach USD 612 billion by the year 2027, driven by technological innovations. The hospitals segment is experiencing robust growth due to a combination of factors, including the increasing number of surgical procedures, technological advancements, and the growing demand for orthopedic, wound care, and aesthetic treatments. Hospitals, as key players in healthcare delivery, are actively adopting bioresorbable collagen implants to enhance patient outcomes and meet evolving medical needs.

Our in-depth analysis of the global market includes the following segments:

           Type

  • Dermal Fillers
  • Orthopedic Implants

 

   

           End User

  • Hospitals
  • Surgical Centers
  • Dermatology Clinics

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Bioresorbable Collagen Implant Industry - Regional Synopsis

APAC Market Forecast

The bioresorbable collagen implant market in the Asia Pacific is projected to hold the largest revenue share of 37% by the end of 2036. Orthopedic surgeries often involve the use of bioresorbable collagen implants for tendon and ligament repair. The region's high incidence of trauma cases contributes to the growth of this segment. Orthopedic procedures account for a significant portion of surgical operations in the Asia-Pacific region, driven by trauma cases and sports injuries. The Asia Pacific region is experiencing robust growth in the market due to factors such as an aging population, increasing healthcare expenditure, a high volume of orthopedic procedures, and patient preferences for minimally invasive techniques and aesthetic enhancements. The alignment of collagen implants with these trends and the region's focus on safety and regulatory compliance further support market expansion.

North American Market Statistics

The bioresorbable collagen implant market in the North America region is projected to hold the second-largest share during the forecast period. An aging population is more susceptible to orthopedic conditions, such as osteoarthritis and ligament injuries. Bioresorbable collagen implants are increasingly used in orthopedic surgeries for tissue repair and regeneration, aligning with the needs of this demographic. North America has a rapidly aging population, with over 16% of its citizens aged 65 and older. North American hospitals and healthcare facilities are early adopters of innovative medical technologies, including bioresorbable collagen implants. Ongoing technological advancements in these implants enhance patient outcomes and drive market growth. The United States alone spends over 17% of its GDP on healthcare, promoting investments in advanced medical technologies.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Bioresorbable Collagen Implant Landscape

    • Allergan, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Zimmer Biomet Holdings, Inc.
    • Galderma S.A.
    • CollPlant Holdings Ltd.
    • Collagen Matrix, Inc.
    • Merz Pharma GmbH & Co. KGaA
    • RegenLab SA
    • Croma-Pharma GmbH
    • Dr. Suwelack AG & Co. KG
    • Mentor Worldwide LLC

In the News

  • Zimmer Biomet acquired Embody, Inc., a privately-held medical device company focused on soft tissue healing, for USD 155 million at closing and up to an additional USD 120 million subject to achieving future regulatory and commercial milestones over three years. The acquisition was aimed at expanding Zimmer Biomet's portfolio of soft tissue healing products and solutions.
  • Zimmer Biomet merged with Biomet, Inc., to form a global leader in musculoskeletal healthcare. The merger combined Zimmer's and Biomet's portfolios of products and solutions, including joint reconstruction, sports medicine, and spine care.

Author Credits:  Radhika Pawar


  • Report ID: 5317
  • Published Date: Oct 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand for healthcare is the major factor driving the market growth.

The market size of bioresorbable collagen implants is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market are Allergan, Inc., Zimmer Biomet Holdings, Inc., Galderma S.A., CollPlant Holdings Ltd., Collagen Matrix, Inc., Merz Pharma GmbH & Co. KGaA, and others.

The hospital segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Bioresorbable Collagen Implant Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample